Tag Archives: NSAIDs

Featured Stories
Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

FDA Strengthens Heart Attack and Stoke Warnings for Nonsteroidal Anti-inflammatory Drugs

FDA Strengthens Heart Attack & Stoke Warnings for NSAIDs

The Food and Drug Administration (FDA) has strengthened existing warnings on prescription and over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs) Drug Facts labels to indicate that the drugs can increase the risk of a heart attack or stroke, which can lead … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , |

Stronger Warning Label Placed on Non-Aspirin NSAIDs

Stronger Warning Label Placed on Non-Aspirin NSAIDs

The warning labels on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) are being strengthened to reflect the the risk of heart attack and stroke, the U.S. Food and Drug Administration (FDA) announced. The agency already warned of this risk in 2005, but … Continue reading

Posted in Legal News | Tagged , , , , |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

FDA Orders Stronger Warnings of Heart and Stroke Risks with Common Pain Relievers

FDA Orders Stronger Warnings with Common Pain Relievers

After reviewing new safety information, the Food and Drug Administration (FDA) has requested drug makers to strengthen warnings that common painkillers like Motrin, Aleve, and Advil can increase the risk of a heart attack or stroke. These painkillers—nonsteroidal anti-inflammatory drugs—are … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

FDA Strengthens Heart Attack/Stroke Warnings for NSAIDs

FDA Strengthens Heart Attack/Stroke Warnings for NSAIDs

The Food and Drug Administration (FDA) is strengthening label warnings that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. After a comprehensive review of new safety information, the agency is requiring updates to the … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

Gastrointestinal Events Common in NSAID Use for Arthritis

Gastrointestinal Events Common in NSAID Use for Arthritis

A European study found gastrointestinal (GI) events continue to be common among patients with rheumatic diseases treated with nonsteroidal anti-inflammatory drugs (NSAIDs). The incidence rate of any GI adverse event was 19 (95% CI 17.3-20.8) per 100 person-years during 6 … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.